摘要
目的探讨美洛西林钠舒巴坦钠治疗肺部感染的药物疗效。方法将我院近期收治的肺部感染患者60例,随机分为观察组和对照组各30例,评定两组药物疗效。结果观察组的总有效率显著高于对照组,差异有统计学意义(P<0.05)。结论美洛西林钠舒巴坦钠治疗肺部感染的效果显著优于美洛西林钠,药物疗效更加确切。
Objective To explore the mezlocillin sulbactam curative effect for the treatment of lung infection. Methods 60 patients with lung infection, recently admitted in our were randomly divided into observation group and control group 30 cases each, curative effect evaluation of two groups of drugs. Results The observation group had a significantly higher than that of control group, the total effective rate of the difference was statistically significant （P〈0,05）. Conclusion Mezlocillin sulbactam for the treatment of pulmonary infection significantly better than that of mezlocillin sodium, drug efficacy is more exact.
出处
《中国医药指南》
2013年第29期4-6,共3页
Guide of China Medicine
